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Abstract
Purpose Approximately 20% of cancers are estimated to have a viral etiology. We aimed to investigate whether DNA of 8 
human parvoviruses [bocavirus 1–4 (HBoV1–4), parvovirus B19 (B19V), protoparvoviruses (bufa-, tusa-, and cutavirus)] 
and 13 human polyomaviruses (HPyV) can be detected in oropharyngeal and oral cavity squamous cell carcinoma (OPSCC/
OSCC), and in juvenile nasopharyngeal angiofibroma (JNA) tissue samples.
Methods Fresh samples of seven JNA tissues and ten paired tissues of OSCC/OPSCC tumor and adjacent healthy tissues 
were collected. DNA extraction and real-time PCRs were performed to detect HBoV1-4, B19V, bufa- tusa- and cutavirus, 
and HPyV genomes.
Results JNA specimens were negative for all parvoviruses tested, whereas one JNA sample was Merkel cell polyomavirus 
(MCPyV) DNA positive. The OSCC/OPSCC samples were negative for the human protoparvoviruses, HBoV1-4, and all 
human polyomaviruses, except for one patient that was MCPyV DNA positive in both healthy and tumor tissues. Seven 
OSCC/OPSCC patients were positive for B19V DNA, three of them in both healthy and cancerous tissues and three in only 
healthy tissues. Three of the B19V DNA-positive patients harbored viral genotype 1, three genotype 2, and one genotype 3B.
Conclusions These are the first reports of MCPyV and B19V DNA being detected in JNA and OPSCC. The significance of 
viral DNA positivity is unclear. B19V DNA is known to remain in the tissues lifelong, however, it is of interest that there 
are some patients with B19 DNA in healthy tissue, but not in the corresponding cancer tissue.
Keywords Juvenile nasopharyngeal angiofibroma · Head and neck cancer · Protoparvovirus · Human parvovirus B19 · 
Bocavirus · Polyomavirus · Merkel cell virus
Introduction
An estimated 15–20% of cancers are a consequence of viral 
infection, such as human papillomaviruses (HPV) in cervi-
cal carcinomas and oropharyngeal squamous cell carcinoma 
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(OPSCC) and hepatitis B and C in liver cancers. However, 
many other known and unknown viruses may trigger car-
cinogenesis through modification of apoptosis, cell division 
and differentiation, as well as signaling cascades [1].
Head and neck squamous cell carcinoma (HNSCC) has 
a worldwide annual incidence of approximately 600,000 
cases [2]. HPV and EBV are widely known etiological fac-
tors for oropharyngeal and nasopharyngeal carcinoma [1], 
respectively. In Western countries in the last few decades, 
the incidence of some HNSCCs has been decreasing, along 
with a decrease in risk factors such as smoking. Despite 
this, the incidence of OPSCC has been increasing, likely in 
conjunction with HPV. However, not all of those infected 
with high-risk HPV develop squamous cell carcinoma [3], 
therefore, it is possible that other viruses act as co-factors. 
Moreover, oral cavity squamous cell carcinoma (OSCC) 
incidence has been rising, especially in < 45-year-old indi-
viduals and patients without typical risk factors or HPV [2]. 
Their etiology needs to be better understood: specifically, 
whether there is an undiscovered viral component.
Juvenile nasopharyngeal angiofibroma (JNA) is a rare, 
highly vascular tumor of the nasopharynx, almost exclu-
sively in young males. It is the most common benign naso-
pharyngeal neoplasm, comprising 0.5% of all head and neck 
tumors. Despite being histologically benign, it is locally 
destructive, and can lead to bony remodeling and even 
intracranial extension [4]. Its etiology is poorly understood. 
However, our preliminary results from previous studies have 
pointed to the possibility of a viral etiology. First, there was 
upregulation of immunological proteins such as TNF alpha 
in a higher stage JNA sample [4]. Additionally, lymphocytes 
and mast cells, usually present in chronic infection, were 
seen within two JNA tissue samples, sparking work to look 
at toll-like receptors (TLR) within JNA samples. The intra-
cellular TLRs 3, 7 and 9, thought to recognize viral nucleic 
acids, have been found within the JNA tissue [5]. Therefore, 
it seemed relevant to investigate a viral etiology for JNA. 
Furthermore, HPV has been discovered in all samples in a 
small JNA cohort [6].
In this study, we aim to investigate the presence of novel 
viruses in both JNA and OPSCC/OSCC, of which there is 
little or no documentation in the literature, given a prece-
dent of viral illness’ role in cancer development. The viruses 
included in this study are 8 human parvoviruses: [parvovirus 
B19 (B19V), bocaviruses (HBoV) 1–4], bufavirus (BuV), 
tusavirus (TuV), and cutavirus (CuV); as well as 13 human 
polyomaviruses (HPyVs): BK, JC, KI, WU, trichodysplasia 
spinulosa (TS), Merkel cell virus (MC), Malawi (MW), St 
Louis (STL), New Jersey, and human polyomaviruses 6, 7, 
9, 12 and 13.
Materials and methods
Clinical specimens
The clinical material comprised fresh JNA tissues from seven 
Finnish males (age range 17–33 years; mean 22.7, median 
22), as well as paired samples of ten tumor and eight healthy 
mucosa from ten patients with OSCC/OPSCC (age range 
31–86 years; mean 61.2, median 59). The healthy tissues were 
taken from healthy buccal mucosa on the contralateral side. 
The patients with OSCC/OPSCC encompassed seven males 
and three females. Nine were Finnish, whereas one male was 
Bulgarian, and had moved to Finland. Tumor information can 
be found in Table 1. Clinical TNM stage was used if the patient 
Table 1  Demographics and details of oral and oropharyngeal tumor specimens, along with parvovirus B19 and Merkel cell polyomavirus status. 
The PCR assays for the remaining viruses tested were all negative
B19V parvovirus B19, MCPyV merkel cell virus, TNM tumor node metastasis, + positive, − negative, N/A not applicable
Gender Age, years Tumor location TNM (all M0) TNM stage Tumor B19V status 
(DNA copies per  106 
cells)
Healthy sample B19V 
status (DNA copies 
per  106 cells)
B19V genotype MCPyV 
presence
OPSCC
 Male 58 Base of tongue T4aN0 IVa + (41) + (251) 1 +
 Male 52 Tonsil pT2pN2a IVa + (6) + (158) 1 −
 Female 66 Soft palate T1N2c IVa + (2) + (12) 2 −
 Male 52 Soft palate pT2bpN2a IVa + (131) + (301) 3B −
 Male 85 Tonsil T2N2 IVa − N/A N/A −
 Male 46 Tonsil T2N2b IVa − + (11) 1 −
 Male 31 Tonsil T2N2b IVa − − N/A −
 Male 76 Tonsil pT2bpN0 II − N/A N/A −
OSCC
 Female 86 Lateral tongue T3N1 IV − + (125) 2 −
 Female 60 Cheek mucosa pT2pN2b IV − + (20) 2 −
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did not have operative treatment and pathological TNM stage 
used if the patient underwent an operation.
All tissues were freshly frozen directly after surgical resec-
tion in the operating theatre. DNA from frozen biopsies were 
extracted using the QIAamp DNA mini kit (Qiagen). All pro-
cedures were carried out according to the manufacturers’ pro-
tocols. The DNA preps were eluted in 100 µl water.
Viral DNA assays
All the real-time qPCR assays were performed with Stratagene 
Mx3005P (Agilent Technologies, USA). Plasmids containing 
either full-length virus genomes or corresponding PCR ampli-
cons were used as amplification standards in each PCR.
An HBoV1-4 multiplex qPCR assay was applied to detect 
HBoV1-4 genomes. The PCR amplifies the HBoV genome 
from the left-hand non-coding region to the beginning of the 
NS1 gene. The plasmids and qPCR protocol are described 
elsewhere [7].
A Pan-B19 qPCR targeting the NS1 gene of the viral 
genome was used to detect and amplify all three B19V geno-
types, as described [8]. To confirm the B19V Gt3B-positive 
samples, a nested PCR was performed to amplify a 1064-bp 
fragment of the VP1 gene, as described [9]. The alignment 
of B19V Gt3B-positive samples was done with MUSCLE 
and the phylogenetic analysis was performed by construct-
ing maximum likelihood trees using PhyML program with 
HKY85 nucleotide substitution model (Phylogeny.fr).
A multiplex real-time qPCR was used for the detection 
of the three human protoparvoviruses, with primers located 
in the NS1 region of BuV and the VP2 region of TuV and 
CuV, as described [10].
DNAs of 13 HPyVs were detected with a Luminex-based 
multiplex assay by targeting the respective VP1 genes of 
HPyVs, as described [11].
All DNA extracts were subjected to the reference gene, 
RNase P, qPCR for quality control and cell-count quantifica-
tion, as described [8].
Ethics/Permissions: This research is part of the “Medical 
significance of new DNA viruses” study, approved by the 
Ethics Committee of Helsinki and Uusimaa Hospital Dis-
trict and the National Supervisory Authority for Welfare 
and Health (Valvira). Written consent was obtained from all 
individual participants included in the study for their tissue 
samples to be collected and used in the research.
Results
JNA samples
All JNA tissue samples were DNA negative for all parvo-
viruses (BuV, TuV, CuV, HBoV1-4 and B19V), as well as 
for all human polyomaviruses, except one sample, from a 
33-year-old patient, which was positive for MCPyV DNA.
Head and neck cancer specimens
All samples were negative for BuV, TuV, CuV and HBoV1-
4. In one patient with a base of tongue cancer, both the tumor 
sample and the matched healthy mucosa were positive for 
MCPyV; the remaining samples were negative for any HPyV 
DNA. However, 11/18 samples from 7 out of 10 patients 
were positive for B19V DNA. Four of these 7 patients had 
B19V DNA in both cancer and healthy tissues, and three 
in only the healthy tissues but not in the cancer. The four 
tumor samples that were positive for B19V DNA were all 
TNM stage IVa. They were of varying tumor types: two of 
the soft palate, one of the base of tongue, one of the tonsil. 
Of the B19V-DNAs detected, three were of genotype 1, three 
of genotype 2, and one of genotype 3B. The latter was from 
a 52-year-old male patient who was originally from Bul-
garia. The viral load was low among all B19V DNA-positive 
samples (mean 96.2, median 41, range 2–301 copies per one 
million human cells). Table 1 shows the details of the tumors 
and patient demographics, along with B19V viral counts and 
genotypes, and HPyV presence.
Discussion
This panel of viruses was selected for varying reasons. 
Polyomaviruses are known to cause tumors in animals, and 
to date MCPyV, discovered in 2008, has been detected in 
70–80% of Merkel cell carcinomas in humans [12]. HBoV1-
4, belonging to the Parvoviridae family, are mainly present 
in respiratory or enteric infections, however, in two studies 
HBoV1 was found in 20% of colorectal and 18% of lung 
cancers [13, 14]. BuV, TuV and CuV are protoparvoviruses 
discovered in pediatric diarrheal stool samples and CuV was 
additionally found in skin lesions of cutaneous T-cell lym-
phoma (CTCL) [15, 16]. It was later detected in both healthy 
and malignant skin of CTCL and immunosuppressed organ 
transplant patients, but not in skin of healthy adults [10]. 
Parvoviruses in general are not considered directly onco-
genic like the polyomaviruses. However, prolonged anti-
gen stimulation by persistent viruses could induce chronic 
inflammatory responses that together with other molecular 
events would lead to cell mutations and cell proliferation. 
Alternatively, parvoviruses could prefer rapidly dividing 
cancer cells for their replication and lyse the target cells, 
thus shrinking or even curing the tumor. It is imperative 
to study if and how viruses like these affect tumor onset, 
progression and outcome.
Previous research detecting viruses within JNA have stud-
ied HPV, human herpesvirus-8 (HHV-8) and EBV: in a small 
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sampling of 6 patients, all were positive for HPV [6], and 
in another study, all 15 JNA tissue samples were negative 
for HHV-8 and EBV [17]. Our results are the first published 
on B19V, HBoV1-4, BuV, TuV, CuV, and 13 HPyVs within 
JNA samples, showing negative findings in all patients 
except one, whose JNA was positive for MCPyV DNA, a 
known oncogenic virus found in the majority of Merkel 
cell carcinomas [12]. This is the first documented case of 
MCPyV DNA within JNA tissue. However, the MCPyV is a 
relatively ubiquitous virus, with a seroprevalence in adults of 
50–95%. The majority of adults further shed MCPyV from 
their skin [12]. Thus, this finding in the oldest patient of the 
cohort could be a reflection of his previous encounter with 
the virus. Although exceedingly rarely, Merkel cell carci-
nomas have been reported within the nasal vestibule [18]; 
therefore, it is conceivable that MCPyV may also be present 
in the sinonasal passages.
In one recent HNSCC study, viral signatures were 
detected from 100 OSCC/OPSCC samples [19]. HPV 16 
was found in 98% of the OSCC/OPSCCs but not in controls, 
and reo-, herpes-, pox-, orthomyxo-, retro- and polyoma-
viruses were found with a hybridization signal level 2–3 
logs higher than in the controls, all showing statistically sig-
nificant differences. The presence of EBV in this study was 
statistically associated with OSCC [20].
A recent study of HPyV DNA detection in 82 HNSCC 
samples by Poluschkin et al. revealed HPyV positivity in 
52% (83% of 29 OSCCs and 0% of 23 OPSCC) [21]. In 
OSCC, JCPyV was present in 59%, SVPyV in 21% and 
BKPyV in 3% of the samples. Interestingly, in 86.2% of 
JCPyV-positive HNSCC samples, there was HPV co-infec-
tion. In our study, one out of eight OPSCC samples was 
positive for HPyV (MCPyV), and both OSCC samples were 
negative for HPyV. The discrepancy between this study and 
our study, both on Finnish patients, could be due to local 
variance, as the patient cohorts were from different regions, 
small sample size, or perhaps due to different methods used 
in the detection of the viruses.
Parvovirus B19 can persist lifelong in human body tis-
sues [22]. Of the patients with B19V DNA-positive tumor 
samples, all harboring genotype 1 were under 60 years of 
age, whereas those with genotype 2 were over 60 years 
of age, correlating with the fact that B19V genotype 2 
widely circulated around 50 years ago, but then disap-
peared from circulation around 1970 [23]. One patient 
was found to harbor, in both healthy and cancerous tis-
sue, DNA of B19V genotype 3, which is extremely rare in 
Finland—indeed, this patient had travelled from Bulgaria. 
Hitherto, only two subjects have been found positive for 
genotype 3 in this region, and they were soldiers from the 
Soviet army killed during World War II [24]. In the cur-
rent study, B19V DNA was present in 11/18 samples of 
7/10 patients, however, in three of the patients the cancer 
tissue was negative for B19V while the paired healthy tis-
sue was positive. The role of B19V existing in the control 
tissues more than the cancer tissues of the same patients 
is unclear at this point.
For the recently discovered boca-, bufa-, tusa-, and cuta-
viruses, this is the first study of their presence in OSCC/
OPSCC, however, CuV has been detected in skin lesions of 
CTCL, melanoma, basal cell and squamous cell carcinomas 
[10, 16, 25].
In conclusion, PCRs for B19V and the emerging parvovi-
ruses HBoV1-4, BuV, TuV, and CuV, as well as for 12 of 13 
HPyVs were negative in the studied JNA samples, whereas 
MCPyV was detected in one. This was the first report of 
MCPyV DNA being found in JNA. The OSCC/OPSCC sam-
ples were DNA positive only for MCPyV in one patient, and 
B19V DNA in 11/18 samples in 70% of the patients, how-
ever, the significance of this viral presence remains unclear.
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